Clinical trial
Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients
NCT00031473 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00031473 |
|---|---|
| Title | Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients |
| Official title | A Randomized Phase III Study to Evaluate the Safety and Efficacy of Ribavirin Inhaled Solution in Preventing Progression of Upper Respiratory Tract Respiratory Syncytial Virus Infection to RSV Pneumonia in Blood and Bone Marrow Transplant (BMT) Recipient |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Respiratory Syncytial Virus Infections |
| Intervention type | Drug |
| Interventions | Virazole (Ribavirin) Inhalation Solution |
| Enrollment | 90 |
| Start date | Nov 1, 1997 |
| Completion | Mar 1, 2003 |
| First posted | Mar 7, 2002 |
| Last update posted | Aug 27, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: